ARTICLE | Clinical News
ProstaScint iII-indium capromab pendetide diagnostic data
November 9, 2009 8:00 AM UTC
In a 10-year patient outcomes study in 239 patients who underwent permanent prostate brachytherapy using ProstaScint imaging in combination with CT scans, bDFS was 93.5% for low-risk patients (n=116),...